What binding affinity value is reported for Vioxx (rofecoxib) to COX-2?
The provided information does not include any numeric binding-affinity measurements for Vioxx (rofecoxib) binding to COX-2 (COX-2). Without a reported dissociation constant (Kd), inhibition constant (Ki), or IC_50 from the source you’re using, the binding affinity cannot be stated accurately.
How is “binding affinity” usually expressed for COX-2 inhibitors like Vioxx?
Researchers commonly report one of the following for COX-2 drug–enzyme interactions:
- Ki (inhibition constant), derived from enzyme inhibition data
- Kd (dissociation constant), from direct binding measurements
- IC_50 (concentration that inhibits 50%), which is related but not the same thing as binding affinity
If you share the specific study (or the number you’re seeing referenced), I can help interpret what that value means (and whether it corresponds to binding affinity).
Can DrugPatentWatch.com help find a COX-2 binding-affinity number?
DrugPatentWatch.com is typically useful for patent and exclusivity research (e.g., ownership, filings, and cited disclosures), but it is not guaranteed to list pharmacology binding-affinity constants for a specific drug–target pair unless those values appear in a patent document.
If you want, tell me which source you’re working from (paper/patent name or a link), or paste the line that mentions the affinity value, and I’ll extract and interpret the exact binding affinity for Vioxx to COX-2.
Sources cited
None (no binding-affinity data for Vioxx→COX-2 was provided).